Swiss Federal Council Ordinance (As of 30-Nov-18)

Total Page：16

File Type：pdf, Size：1020Kb

Swiss Federal Council Ordinance (as of 30-Nov-18) EQUITY SECURITIES OF SWISS INCORPORATED COMPANIES WITH DUAL-LISTING (PRIMARY / SECONDARY) IN EU # ISIN Company Symbol Country Other listing location Comment 1 CH0012221716 ABB Ltd ABBN CH Nasdaq OMX Stockholm (22.06.1999) Dual primary listed on NOMX and SIX; NYSE (05.09.2001): ADR 2 CH0043238366 ARYZTA AG ARYN CH Irish Stock Exchange 3 CH0038389992 BB Biotech AG BION CH Deutsche Börse – Prime Standard Segment and Borsa Italiana – Star Segment 4 CH0014345117 Compagnie financière Tradition S.A. CFT CH Frankfurt Stock Exchange (Third Market Segment) 5 CH0012214059 LafargeHolcim Ltd LHN CH Euronext Paris Dual primary listed on Euronext and SIX COMPANIES NOT INCORPORATED IN SWITZERLAND WITH PRIMARY LISTING ON SIX # ISIN Company Symbol Country Other listing location Comment 1 AT0000A18XM4 ams AG AMS AT 2 IT0005108359 Cassiopea S.p.A. SKIN IT 3 NL0011832936 COSMO Pharmaceuticals N.V. COPN NL 4 VGG290991014 Eastern Property Holdings Limited EPH VG 5 VGG3637V1094 Formulafirst Ltd. FFI VG 6 AT0000KTMI02 KTM Industries AG KTMI AT Wiener Börse 7 NL0010733960 lastminute.com N.V. LMN NL 8 LI0355147575 Liechtensteinische Landesbank AG LLBN LI 9 GG00B247Y973 LumX Group Limited LUMX GG 10 IT0004147952 Newron Pharmaceuticals S.p.A. NWRN IT 11 GB00BLG2TX24 Rapid Nutrition PLC RAP GB 12 IL0010855885 SHL Telemedicine Ltd. SHLTN IL 13 LI0315487269 VP Bank AG VPBN LI Source: SIX Website (https://www.six-group.com/exchanges/shares/companies/issuer_list_en.html) Disclaimer: The present document has been prepared by SIX Swiss Exchange to the best of its knowledge and belief. SIX Swiss Exchange assumes no responsibility whatsoever e.g. with regard to the accuracy, correctness, completeness, timeliness or appropriateness of the information contained therein. In particular, SIX Swiss Exchange shall in no circumstances be held liable or assume any responsibility with regard to the fact that trading activities of the recipient lead to loss, damages or violence of statutory law as a result of the list not being complete, correct or up to date. This document serves for information purposes only and does not intend to provide professional legal or any other kind of advice. Please contact your professional advisor for assistance in respect of the ordinance of the Swiss Federal Council on the Recognition of Foreign Trading Venues for trading in equity securities of companies domiciled in Switzerland of 30 November 2018 (“Verordnung über die Anerkennung ausländischer Handelsplätze für den Handel mit Beteiligungspapieren von Gesellschaften mit Sitz in der Schweiz“) and in particular the exceptions pursuant to Art. 1 para. 2 of such Ordinance. Please note that the content of this document is intended for the confidential use of the person addressed and shall not be further disclosed or distributed..

Copy Link

Recommended publications

Market Notice Date: 14 November 2019 Market Notice Number: 112/2019
Market Notice Date: 14 November 2019 Market Notice Number: 112/2019 Equiduct Universe Change Please see today's changes below effective 18 November 2019: Trading Reporting MIC Settlement Trading Settlement Tick Size Change/ Security Name ISIN Home Market Symbol Country Currency Currency table Action ABB LTD ABBNz CH0012221716 XSWX EQTB CH CHF CHF ESMA_E Deletion ABB ABBs CH0012221716 XSTO EQTB SE SEK SEK ESMA_E Deletion ADECCO SA ADENz CH0012138605 XSWX EQTC CH CHF CHF ESMA_E Deletion AMS AG AMSz AT0000A18XM4 XSWX EQTC CH CHF CHF ESMA_E Deletion ARYZTA AG ARYNz CH0043238366 XSWX EQTB CH CHF CHF ESMA_E Deletion JULIUS BAER GRUPPE AG BAERz CH0102484968 XSWX EQTC CH CHF CHF ESMA_E Deletion BALOISE-HLDGS BALNz CH0012410517 XSWX EQTC CH CHF CHF ESMA_D Deletion BARRY CALLEBAUT AG BARNz CH0009002962 XSWX EQTC CH CHF CHF ESMA_D Deletion BB BIOTECH BBZAd CH0038389992 XETR EQTB DE EUR EUR ESMA_D Deletion BB BIOTECH BIONz CH0038389992 XSWX EQTB CH CHF CHF ESMA_D Deletion BASILEA PHARMACEUTICA AG BSLNz CH0011432447 XSWX EQTC CH CHF CHF ESMA_D Deletion BUCHER INDUSTRIES BUCNz CH0002432174 XSWX EQTC CH CHF CHF ESMA_D Deletion COMPAGNIE FINANCIERE RICHEMONT CFRz CH0210483332 XSWX EQTC CH CHF CHF ESMA_E Deletion CLARIANT CLNz CH0012142631 XSWX EQTC CH CHF CHF ESMA_E Deletion CEMBRA MONEY BANK AG CMBNz CH0225173167 XSWX EQTC CH CHF CHF ESMA_D Deletion CREDIT SUISSE GROUP AG CSGNz CH0012138530 XSWX EQTC CH CHF CHF ESMA_E Deletion DKSH HOLDING DKSHz CH0126673539 XSWX EQTC CH CHF CHF ESMA_D Deletion DORMA+KABA HOLDING AG DOKAz CH0011795959 XSWX EQTC CH CHF
[Show full text]
Ntqlrethih1it6katsuy79yjfy6.Pdf
Global Research 16 March 2021 Aryzta AG Equities Improved business model set up - upgrade to Buy Switzerland Food Products 12-month rating Buy * Upgrade to Buy after key corporate actions Prior: Neutral Aryzta has gone through challenging times but we believe new management actions 12m price target CHF1.50 unlock value prospects. We upgrade the stock to Buy from Neutral and raise our price Prior: CHF0.65 target to CHF1.5. In our view, the announced divestment of the underperforming Price (15 Mar 2021) CHF1.04 region North America with related proceeds (c€700m – transaction multiple c10.5x FY 20) used to de-lever the balance sheet is a game changer. Aryzta can now focus on the RIC: ARYN.S BBG: ARYN SW key value driver Europe. The improving balance sheet allows growth investments. With Trading data and key metrics c60% exposure to street traffic, we also think Aryzta should benefit from easing 52-wk range CHF1.04-0.29 COVID-19 mobility restrictions. We expect a strong net profit recovery to €81m by FY Market cap. CHF1.03bn/US$1.10bn 23E (FY 21E -€61m). The stock has EFCF run rate prospects of €70-100m medium term Shares o/s 990m (REG ) resulting in an attractive yield to market cap of 7-10% (Swiss mid cap food companies Free float 100% trade at 2-4%). Avg. daily volume ('000) 6,794 Restructuring on track and attractive exposure to consumer street traffic Avg. daily value (m) CHF5.4 To optimise the business model set up in Europe, Aryzta is de-layering management, Common s/h equity (07/21E) €0.19bn resulting in cost savings of c€20-30m (UBSe), but at the same time it is strengthening P/BV (07/21E) 4.9x local responsibility and client relations.
[Show full text]
Julius Baer Multistock Société D'investissement À Capital Variable
Julius Baer Multistock Société d'Investissement à Capital Variable Annual Report as at 30 June 2011 (audited) Subscriptions are carried out solely on the basis of the current prospectus or the simplified prospectus, or the “key investor information”, as soon as it is available, in conjunction with the latest annual report and the latest semi-annual report if published thereafter. The articles of association, the valid prospectus and the simplified prospectus, the annual and semi-annual reports (or the “key investor information”, as soon as it is available), as well as the information based on the SFA guidelines on transparency with regard to management fees, may be obtained free of charge from the representative in Switzerland and/or from the respective paying agent. In case of differences between the German version and the translation, the German version shall be the authentic text. AN INVESTMENT FUND DOMICILED IN LUXEMBOURG Representative in Switzerland: Swiss & Global Asset Management AG, Hardstraße 201, CH - 8005 Zurich (new address from 19 September 2011) Paying agent in Switzerland: Bank Julius Bär & Co. AG, Bahnhofstraße 36, Postfach, CH - 8010 Zurich Paying and information agent in Germany (until 31 December 2010): Bank Julius Bär Europe AG, An der Welle 1, Postfach 15 02 52, D - 60062 Frankfurt am Main Paying agent in Germany (since 1 January 2011): Deka Bank Deutsche Girozentrale, Hahnstraße 55, D - 60528 Frankfurt am Main Information agent in Germany (since 1 January 2011): Swiss & Global Asset Management Kapital AG, Taunusanlage 15, D - 60325 Frankfurt am Main Paying agent in Austria: Erste Bank der oesterreichischen Sparkassen AG, Graben 21, A - 1010 Vienna Representative and paying agent in Liechtenstein: LGT Bank in Liechtenstein AG, Herrengasse 12, FL - 9490 Vaduz Trade and Companies Register number: R.C.S.
[Show full text]
Geneva, May 15, 2017 MSCI GLOBAL STANDARD INDEXES The
Geneva, May 15, 2017 MSCI GLOBAL STANDARD INDEXES The following are changes in constituents for the MSCI Global Standard Indexes which will take place as of the close of May 31, 2017. SUMMARY PER COUNTRY and PER REGION: Nb of Nb of Securities Securities Region Country Added Deleted Asia Pacific AUSTRALIA 1 1 JAPAN 3 2 HONG KONG 0 1 MALAYSIA 0 2 TAIWAN 2 1 KOREA 3 0 INDIA 2 1 PAKISTAN 6 0 CHINA 5 3 Nb of Nb of Securities Securities Region Country Added Deleted Europe, Middle East and Africa UNITED ARAB EMIRATES1 0 SWITZERLAND 1 1 DENMARK 1 0 SPAIN 1 2 FRANCE 1 1 ITALY 1 0 UNITED KINGDOM 1 1 TURKEY 1 0 SOUTH AFRICA 0 1 RUSSIA 1 0 EGYPT 1 1 Nb of Nb of Securities Securities Region Country Added Deleted Americas USA 22 7 CANADA 1 1 BRAZIL 1 1 COLOMBIA 1 1 ASIA PACIFIC MSCI AUSTRALIA INDEX Additions Deletions BLUESCOPE STEEL VOCUS GROUP MSCI JAPAN INDEX Additions Deletions DISCO CORP HOKURIKU ELECTRIC POWER KYUSHU RAILWAY CO MITSUBISHI LOGISTICS TOSOH CORP MSCI HONG KONG INDEX Additions Deletions None CATHAY PACIFIC AIRWAYS MSCI MALAYSIA INDEX Additions Deletions Page 1 MSCI Global Standard Indexes - May 15, 2017 © MSCI 2017, All rights reserved None BERJAYA SPORTS TOTO LAFARGE MALAYSIA MSCI TAIWAN INDEX Additions Deletions GLOBALWAFERS CASETEK HOLDINGS TAIWAN HIGH SPEED RAIL MSCI KOREA INDEX Additions Deletions DOOSAN BOBCAT None MEDY-TOX PANOCEAN MSCI INDIA INDEX Additions Deletions INDIAN OIL CORP DIVI'S LABORATORIES RURAL ELECTRIFICATION CO MSCI PAKISTAN INDEX Additions Deletions ENGRO CORPORATION None HABIB BANK LUCKY CEMENT MCB BANK OIL
[Show full text]
2018 Compensation Report to a Principles Applicable to Performance-Related Pay and to the Consultative Vote at the 2019 Annual General Meeting
84 Givaudan – 2018 Integrated Annual Report 85 Compensation report In this section 86 Compensation governance 87 Compensation principles 88 Compensation of Givaudan executives 93 Compensation of the Executive Committee 94 Compensation of the Board of Directors 96 Share ownership guidelines 96 Ownership of Givaudan securities 97 Report of the statutory auditor Givaudan – 2018 Integrated Annual Report 86 Compensation report Compensation report Attract, motivate and retain performance targets and related payouts under the annual incentives and share-based long-term incentives, while the Givaudan aims to attract, applicable performance criteria are set by the Board. motivate and retain a diverse The Compensation Committee is also responsible for pool of highly talented people to reviewing and approving individual compensation and benefits of each Executive Committee member as well as sustain its leadership position recommending compensation for the Board. within the flavour and fragrance The Compensation Committee consists of three independent industry. The Company’s members of the Board and is currently chaired by Prof. Dr-Ing. Werner Bauer. The Chief Executive Officer is regularly invited to compensation policies are an Compensation Committee meetings. The Head of Global Human Resources acts as secretary of the Compensation Committee. essential component of this The Chairman of the Compensation Committee may invite other strategy, and as such a key driver executives as appropriate. However, executives do not participate in discussions regarding their own compensation. of organisational performance. The Compensation Committee meets three to five times a year Our compensation programmes are aligned to our strategy and and informs the Board of its deliberations, recommendations and reflect the performance of the business and of individuals.
[Show full text]
Dividend and Compensation Payments in Light of Covid-19 Pandemic
DIVIDEND AND COMPENSATION PAYMENTS IN LIGHT OF COVID-19 PANDEMIC Information as of 18 November 2020 Annual General Meeting 2019 dividend Company Index Short-time work Board compensation Executive compensation (2020) (paid 2020) ABB SMI unchanged (26.03.2020) unchanged CHF 0.80 - 10% reduction of board compensation for the duration of the 10% reduction of salary for the duration of the crisis crisis Adecco SMI unchanged (16.04.2020) unchanged CHF 2.50 yes - - Aevis Other unchanged (30.04.2020) cancelled - - - Alcon SMI unchanged (06.05.2020) postponed to 2021 - - - Also Other unchanged (24.03.2020) unchanged CHF 3.25 - - - ams SMIM unchanged (03.06.2020) - - - - APG/SGA Other unchanged (14.05.2020) cancelled (from CHF 11.00) yes - 20% reduction of base salary Aryzta Other postponed to 15.12.2020 postponed yes 30% reduction of fees for 3 months 30% reduction salary reduction for 3 months (15% for wider leadership team) Autoneum Other unchanged (25.03.2020) cancelled yes - 10% reduction of base salary Baloise SMIM unchanged (24.04.2020) unchanged CHF 6.40 - - - Barry Callebaut SMIM unchanged (09.12.2020) - - - - BB Biotech SMIM unchanged (19.03.2020) unchanged CHF 3.40 - - - Bobst Other unchanged (07.04.2020) unchanged CHF 1.50 - - - Bossard Other unchanged (08.04.2020) reduced by 50% to CHF 2.00 4% reduction of compensation 4% salary reduction Bucher Industries SMIM unchanged (24.04.2020) unchanged CHF 8.00 yes (mainly FR and IT) - - BVZ Other unchanged (16.04.2020) reduced to CHF 7.50 - - - Calida Group Other brought forward to cancelled
[Show full text]
Voting Report 2020
Exercising of Shareholder Rights – Information December 2020 As a result of the adoption of the “Popular Initiative against Fat-Cat Salaries” in 2014, pension funds have an obligation to exercise shareholder rights in the interests of the insured persons and to disclose how the pension funds voted. This regulation applies for public limited companies with registered office in Switzerland and whose shares are listed on a domestic or foreign stock exchange. The Foundation Board of the PensFlex Collective Foundation has incorporated the corresponding regulations into the Art. 3.5 of the Organisational Rules or Art. 4 of the Rules on Investment. A list of the voting record of the PensFlex Collective Foundation in the year 2020 is shown below. Voting Report for PensFlex Sammelstiftung Kauffmannweg 16 6003 Luzern This report summarizes voting behaviour according to the following specifications: Time period: 01.01.2020 - 31.12.2020 Agenda items: Summary of all items on the agenda, i.e. not only the items requiring a vote according to Art. 22 para. 1 ORAb. The voting rights were exercised for the following companies: Perrot Duval 06.02.2020 Kardex 14.04.2020 Novartis 28.02.2020 Tornos 15.04.2020 Dätwyler 11.03.2020 Georg Fischer 15.04.2020 Roche 17.03.2020 Sulzer 15.04.2020 BB Biotech 19.03.2020 Evolva 15.04.2020 Schindler 19.03.2020 Mikron 15.04.2020 Swiss Prime Site 24.03.2020 Ascom 15.04.2020 Implenia 24.03.2020 Kudelski 15.04.2020 Bellevue 24.03.2020 Adecco 16.04.2020 SGS 24.03.2020 Rieter 16.04.2020 ALSO 24.03.2020 Cembra Money Bank 16.04.2020
[Show full text]
EB Aug2017.Pdf
EUROBIZ JAPAN EUROBIZ JAPAN • The negotiator An interview with Mauro Petriccione, chief negotiator for the EU-Japan EPA AUGUST 2017AUGUST • Ahead of the pack The enduring popularity of European bicycles in Japan AUGUST 2017 OLIVER RYF, MANAGING DIRECTOR OF ARYZTA JAPAN O T ISING T HE TOP Aryzta Japan sees its R success leavening THE MAGAZINE OF THE EUROPEAN BUSINESS / THE EUROPEAN COUNCIL CHAMBER OF (EU) COMMERCE IN JAPAN IN JAPAN RISING TO THE TOP Contents August 2017 4 34 First Focus Executive Notes Low market volatility 9 By Tom Elliott From the Editor 20 By Andrew Howitt 35 In Committee 10 Financial Reporting Investing in Japan By Geoff Botting Oliver Ryf, Aryzta Japan By Gavin Blair 39 Eurobiz Poll 14 Punish distracted pedestrians? Ahead of the pack The enduring popularity of 41 European bicycles in Japan Illuminating Voices By Gordon Knight Giver of new dreams By Andrew Howitt 18 A way out for 43 overworked Japan 14 Cellar Notes Forward-thinking businesses The sommelier craze offer alternative work styles By Allison Bettin By Alena Eckelmann 44 20 Down Time The Interview Edward Cole / Mauro Petriccione Fernando Iglesias By Andrew Howitt 45 24 On the Green Country Spotlight Golf for the world Switzerland By Fred Varcoe 30 47 EBC Personality The Agenda Peter Kronschnabl By Andrew Howitt 30 48 Work Place 32 Yukari Kagami, Dormeuil Japon Event Report EBC Tax Seminar 2017 By Andrew Howitt 33 Innovations The Mission of the European Business Council Advice from algorithms To promote an impediment-free By Tim Hornyak environment for European business in Japan.
[Show full text]
Annual Report and Accounts WELCOME to ARYZTA AG
2016 Annual Report and Accounts WELCOME TO ARYZTA AG ARYZTA AG (‘ARYZTA’) is an international food business with a leadership position in speciality bakery. ARYZTA is based in Zurich, Switzerland, with operations in North America, Europe, Asia, Australia, New Zealand and South America. ARYZTA has a primary listing on the SIX Swiss Exchange and a secondary listing on the ISE Irish Exchange (SIX: ARYN, ISE: YZA). ARYZTA AG Annual Report 2016 1 Table of Contents Annual Report and Accounts 2016 Page Overview 02 Financial Highlights 03 Letter to Shareholders 06 Business Overview 10 Financial and Business Review 24 Bridge to Group Income Statement Overview Governance 26 Corporate Governance Report 49 Compensation Report 59 Group Risk Statement 61 Our Responsibility Governance Group 65 Group Consolidated Financial Statements Company 145 Company Financial Statements 158 Investor Information Group Company ARYZTA AG Annual Report 2016 2 Annual Report and Accounts 2016 Financial Highlights Group Revenue EBITA1 Underlying Underlying fully in EUR m in EUR m net profit diluted EPS in EUR m in EUR cent 566 4,809 377 80 4,504 422.2 360 52 402.2 1,415 4,208 476 30 319 59.2 1,418 33.3 444 3,877 69 360.3 514 51 291 1,340 3 37.5 69 393 486 57.3 1,300 310.1 485 44 330 260 325 51.5 71 312 42 50.1 368.9 407 363.0 3,820 3,879 268 350.3 375 247 3,394 Overview 303.0 322 3,086 218 286.0 2,868 260.0 2,577 2015 2016 2015 2016 2015 2016 2015 2012 2012 2012 2012 2013 2013 2013 2013 2011 2011 2011 2011 2014 2014 2014 2014 2016 continuing operations discontinued operations
[Show full text]
Julius Baer Multistock Société D'investissement À Capital Variable
Julius Baer Multistock Société d'Investissement à Capital Variable Annual Report as at 30 June 2015 (audited) Subscriptions are carried out solely on the basis of the current prospectus or the key investor information, in conjunction with the latest annual report and the latest semi- annual report if published thereafter. The articles of association, the valid prospectus and the key investor information, the annual and semi-annual reports, as well as the information based on the SFAMA guidelines on transparency with regard to management fees, may be obtained free of charge from the representative in Switzerland and/or from the respective paying agent. In case of differences between the German version and the translation, the German version shall be the authentic text. AN INVESTMENT FUND DOMICILED IN LUXEMBOURG Representative in Switzerland: GAM Investment Management (Switzerland) AG, Hardstraße 201, P.O. Box, CH - 8037 Zurich Paying agent in Switzerland: Bank Julius Bär & Co. AG, Bahnhofstraße 36, P.O. Box, CH - 8010 Zurich Paying agent in Germany: DekaBank Deutsche Girozentrale, Hahnstraße 55, D - 60528 Frankfurt / Main Information agent in Germany: GAM (Deutschland) AG, Taunusanlage 15, D - 60325 Frankfurt am Main Paying agent in Austria: Erste Bank der oesterreichischen Sparkassen AG, Graben 21, A - 1010 Vienna Trade and Companies Register number: R.C.S. Luxembourg B-32188 Contents Page Organisation and Management 4 Information on risk management (unaudited) 6 Audit Report 7 Report of the Board of Directors 9 Notes to the Annual Report
[Show full text]
SIX Swiss Exchange Message No. 42/2018
SIX Swiss Exchange message no. 42/2018 Subject Change of trading segments due to the ordinary index review Category Index Adjustments Authorized by Adrian Isler, Head Market Operations Björn Schaub, Head Exchange Operations Pages 2 Date 24.08.2018 Information Content of this message: - New trading segment for ams AG, Temenos AG, Bâloise Holding AG and ARYZTA AG as of 24 September 2018 - New stop trading range for VAT Group AG, BB Biotech AG, DKSH Holding AG and Galenica AG as of 24 September 2018 On 6 July 2018, SIX Swiss Exchange published SIX Swiss Exchange message No. 30/2018 to announce the impending index adjustments decided by the Index Commission on the occasion of the regular index review. This message provides the most important information on the impact of these index adjustments. Changes to the trading segments With the index adjustment, ams AG and Temenos AG will be included in the SLI® Index and Bâloise Holding AG and ARYZTA AG will be excluded from the SLI® Index. Therefore, these securities will also move to different trading segments effective from 24 September 2018. ams AG and Temenos AG will move from the Mid-/Small-Cap Shares segment (market code XSWX) to the Blue Chips Shares segment (market code XVTX). At the same time, Bâloise Holding AG and ARYZTA AG will move from the Blue Chip Shares segment (market code XVTX) to the Mid-/Small-Cap Shares segment (market code XSWX). Due to change of trading segment, all outstanding orders for these securities will be deleted from the order books: On 21 September 2018 (the last trading day before the segment change), after close of trading at 17:30 CEST, all “good-till-date” orders for these securities will be deleted from the order books by SIX Swiss Exchange.
[Show full text]
Annual Report 2017/18 2
Annual Report 2017/18 “We are the heart and engine of the chocolate and cocoa industry” Key figures 2017/18 Sales Volume EBIT Net Profit Free cash flow Proposed dividend +6.3% +21.2% in local currencies +31.0% in local currencies Payout ratio 37% 2 million 554.0 357.4 311.9 24.00 tonnes CHF million CHF million CHF million CHF per share Sales Volume Sales Revenue In tonnes In CHF million 2'400'000 7,500 2'000'000 6,000 1'600'000 4,500 1'200'000 3,000 800'000 400'000 1,500 0 0 2013/14 2014/15 2015/16 2016/17 2017/18 2013/14 2014/15 2015/16 2016/17 2017/18 EBIT Net profit for the year In CHF million In CHF million 600 360 500 300 400 240 300 180 120 200 60 100 0 0 2013/14 2014/15 2015/16 2016/17* 2017/18 2013/14 2014/15 2015/16 2016/17* 2017/18 * See page 48, Summary of Accounting Policies – Restatement and reclassification of prior year comparatives. Sales Volume by Region Sales Volume by Product Group In tonnes In tonnes 12% EMEA 925,144 22% Food Manufacturers 1,338,311 22% Americas 549,287 Products Asia Pacific 105,777 46% Cocoa Products 455,649 Global Cocoa 455,649 Gourmet & Specialties 241,897 5% Products 66% 27% Barry Callebaut | Annual Report 2017/18 2 Fiscal year 2017/18 in brief • Sales volume up +6.3%, well above the market growth1, first time over 2 million tonnes • Operating profit (EBIT, recurring) up +21.2% in local currencies (+25.3% in CHF) to CHF 554.0 million • Net profit (recurring) up +31.0% in local currencies (+35.9% in CHF) to CHF 357.4 million • Free cash flow of CHF 311.9 million • On track to deliver on mid-term guidance2 • Board member James (Jim) Donald will not stand for reelection.
[Show full text]